文传商讯

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Pru
2024-12-14 03:09:54

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transfor
2024-12-14 03:09:54

New Survey of VMware Customers Reveals Strong Desire to Maximize the Value of Perpetual Licenses
2024-12-14 03:09:54

MBK Partners and Young Poong to Restore Korea Zinc's Shareholder Value through Governance Reform
2024-12-14 03:09:54